Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.

Míreanna comhchosúla

• The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
  de réir: Pitsavos, C, et al.
  Foilsithe / Cruthaithe: (2009)
• Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia
  de réir: Toutouzas, K, et al.
  Foilsithe / Cruthaithe: (2017)
• Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
  de réir: Charakida, M, et al.
  Foilsithe / Cruthaithe: (2009)
• Homocysteine: a risk factor for coronary artery disease?
  de réir: Marinou, K, et al.
  Foilsithe / Cruthaithe: (2005)
• Nitric oxide in coronary artery disease: Effects of antioxidants
  de réir: Tousoulis, D, et al.
  Foilsithe / Cruthaithe: (2006)